Rhonda Patrick· PhD
we know that there are more uh they're going to decline more faster than the people that have low levels of these biomarkers so we have some predictive value of looking into vascular dysfunction
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
we know that there are more uh they're going to decline more faster than the people that have low levels of these biomarkers so we have some predictive value of looking into vascular dysfunction
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.